Baidu-(NASDAQ-BIDU), a Chinese language internet search provider, is recently up $4.00 to $324 in pre-open trading. The company will report earnings on 10/25. Smith Barney has a $250 price target. November option implied volatility of 89 is above its 26-week average of 56 according to Track Data, suggesting larger price fluctuations.

Vertex Pharma-(NASDAQ-VRTX), is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. The company sold off on 10/18/07 after promising trial data from Schering Plough's-(NYSE-SGP) Hepatitis C drug boceprevir was seen as a threat to VRTX's Telaprevir. Option volume was heavy on 54,154 contracts. November option implied volatility of 75 is above its 26-week average of 48 according to Track Data, suggesting larger price fluctuations.

Daily options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Baidu (NASDAQ: BIDU), a Chinese-language internet search provider, is recently down $33.10 to $310.09. BIDU call option volume of 95,184 contracts compares to put volume of 67,862 contracts. BIDU October 330 straddle is priced at $35.50. BIDU November option implied volatility of 90 is above its 26-week average of 55, according to Track Data, suggesting larger price fluctuations.

Regeneron (NASDAQ: REGN), is primarily focused on the development of drugs for oncology. REGN is recently up $0.59 to $19.09. REGN October 20 calls have traded 42 times on transaction volume of 881 contracts, above its open interest of 710 contracts. REGN November call option implied volatility is at 85, puts are at 73 above its 26-week average of 56, according to Track Data, suggesting larger risk.

Volatility Index S&P 500 Options: VIX.X up 2.54 to 19.21.

Daily options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.